Maintenance fees coming due

Shire LLC

9 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Dec 27, 2026. Unpaid by Jun 28, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 11,684,632	Maribavir Isomers, Compositions, Methods of Making and Methods of Using Shire Viropharma LLC In force Fee due Dec 27, 2026 Lapses if unpaid Jun 28, 2027 Term ends Jan 8, 2032 · High confidence	Shire Viropharma LLC	In force	Dec 27, 2026	Jun 28, 2027	Term ends Jan 8, 2032	High confidence
US 11,787,796	Plasma Kallikrein Inhibitors and Uses Thereof Shire Human Genetic Therapies, Inc. In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 Term ends Jan 1, 2041 · High confidence	Shire Human Genetic Therapies, Inc.	In force	Apr 17, 2027	Oct 18, 2027	Term ends Jan 1, 2041	High confidence
US 10,485,813	Maribavir Isomers, Compositions, Methods of Making and Methods of Using Shire Viropharma LLC In force Fee due May 26, 2027 Lapses if unpaid Nov 26, 2027 Term ends Jan 9, 2032 · High confidence	Shire Viropharma LLC	In force	May 26, 2027	Nov 26, 2027	Term ends Jan 9, 2032	High confidence
US 10,487,571	Pass Through Access Opening Closure Device Shire Valley Design, LLC In force Fee due May 26, 2027 Lapses if unpaid Nov 26, 2027 Term ends Feb 14, 2039 · High confidence	Shire Valley Design, LLC	In force	May 26, 2027	Nov 26, 2027	Term ends Feb 14, 2039	High confidence
US 9,206,235	Peptide Linkers for Polypeptide Compositions and Methods for Using Same Shire Human Genetic Therapies, Inc. In force Fee due Jun 8, 2027 Lapses if unpaid Dec 8, 2027 Ends no later than Jul 19, 2031 · Medium confidence	Shire Human Genetic Therapies, Inc.	In force	Jun 8, 2027	Dec 8, 2027	Ends no later than Jul 19, 2031	Medium confidence
US 10,512,657	Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases Shire Human Genetic Therapies, Inc. In force Fee due Jun 24, 2027 Lapses if unpaid Dec 27, 2027 Term ends Oct 26, 2032 · High confidence	Shire Human Genetic Therapies, Inc.	In force	Jun 24, 2027	Dec 27, 2027	Term ends Oct 26, 2032	High confidence
US 10,568,941	Treatment of Cognitive Impairment of Hunter Syndrome by Intrathecal Delivery of IDURONATE-2-Sulfatase Shire Human Genetic Therapies, Inc. In force Fee due Aug 25, 2027 Lapses if unpaid Feb 25, 2028 Term ends Dec 21, 2032 · High confidence	Shire Human Genetic Therapies, Inc.	In force	Aug 25, 2027	Feb 25, 2028	Term ends Dec 21, 2032	High confidence
US 11,938,174	Compositions and Methods Useful for the Treatment of Neuromyelitis Optica Spectrum Disorders Shire Viropharma LLC In force Fee due Sep 26, 2027 Lapses if unpaid Mar 27, 2028 Term ends Nov 12, 2034 · High confidence	Shire Viropharma LLC	In force	Sep 26, 2027	Mar 27, 2028	Term ends Nov 12, 2034	High confidence
US 11,969,703	Antibody-Resin Coupling Apparatus and Methods Takeda Pharmaceutical Company Limited In force Fee due Oct 30, 2027 Lapses if unpaid May 1, 2028 Term ends Dec 24, 2038 · High confidence	Takeda Pharmaceutical Company Limited	In force	Oct 30, 2027	May 1, 2028	Term ends Dec 24, 2038	High confidence

9 of 9 patents shown. Soonest fee due date first, then patent number.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.